Skip to main content
OpenTrials
Completed

NCT Number: NCT05488301

Effects of Chest Physiotherapy in Hyperventilation Syndrome

Hyperventilation syndrome induce dyspnea and altered quality of life. the aim of this study is to assess the impact of chest physiotherapy on hyperventilation syndrome' symptoms

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperventilation Anxiety Disorders Dyspnea Mental Disorders Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

BEAUMONT

Morlaix, 29600, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients addressed for hyperventilation syndrome
  • patient aged 18 years or over
  • patient able to consent and having sign a consent form

Exclusion criteria

  • respiratory disease (COPD, interstitial lung disease, bronchiectasis, cystic fibrosis, uncontrolled asthma)
  • patient with an inability to complete questionaires
  • refusal of participation
  • patient under tutorship or curatorship

Treatment and study plan

chest physiotherapy

Other

chest physiotherapy session including:

  • nasal ventilation
  • decrease of respiratory rate without increasement of Tidal volume
  • abdomino-diaphragmatic ventilation

Primary outcomes

  1. change of Nijmegen score

    Time frame: 5 weeks

    Nijmegen score is measured at baseline and after 5 weeks. The Nijmegen questionnaire allows to assess hyperventilation symptoms. the minimum and maximum values are between 0 to 64, and higher scores mean a worse outcome.

Secondary outcomes

  1. change of Nijmegen Score

    Time frame: 1 week

    Nijemegen score is measured at baseline and after 1 week. The Nijmegen questionnaire allows to assess hyperventilation symptoms the minimum and maximum values are between 0 to 64, and higher scores mean a worse outcome.

  2. change of Hospital Anxiety and Depression score (HAD)

    Time frame: 5 weeks

    Anxiety and depression scores are measured at baseline and after 5 weeks. the minimum and maximum values are between 0 to 21 for each item (Anxiety and Depression), and higher scores mean a worse outcome.

  3. change of Short Form-36 score (SF-36)

    Time frame: 5 weeks

    SF 36 score is measured at baseline and after 5 weeks. SF36 allows to assess quality of life.

    the minimum and maximum values are between 0 to 100, and higher scores mean a better outcome.

  4. change of Dyspnea-12 score

    Time frame: 5 weeks

    Dyspnea-12 is measured at at baseline and after 5 weeks.

    Dyspnea-12 questionnaire allows to assess sensorial and emotional component of dyspnea. The minimum and maximum values are between à to 36, and higher scores mean a worse outcome.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier des Pays de Morlaix

Other

Registry information

Official study title

Effects of Chest Physiotherapy in Hyperventilation Syndrom : a Multicentric Observational Study

Acronym: SHV

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Aug 4, 2022
Registry last updated
Aug 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.